The primary objective of this study, comparing ART 44 to ART 50, will be the evaluation of digestive tolerability (and in particular of diarrhoea).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
210
To demonstrate the better digestive tolerability of ART44 versus ART 50 over a 1-month period, based on a clinically predetermined difference
Time frame: Day 8, Day 0, Week 2, Week 4 and Week 12
To compare the overall safety and efficacy of the two products
Time frame: Day 8, Day 0, Week 2, Week 4 and Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.